Li, Xutong
Xu, Honghai
Chang, Yu
Zhang, Yani
Xu, Hui
Yin, Xin
Zhang, Wanxiang
Luo, Yi
Lu, Wanting
Fan, Wenhu
Ruan, Wanwan
Shen, Jiapei
Li, Zhenxing
Du, Shucheng
Bentum-Ennin, Lutterodt
Ni, Jing
Gao, Wei
Li, Jiabin
Hu, Wanglai
Yang, Wanshui
Gao, Yufeng
Gu, Hao
Funding for this research was provided by:
National Natural Science Foundation of China (82373673)
National Natural Science Foundation of China (82370608)
National Key Research and Development Program of China (2023YFA1800800)
Natural Science Foundation of Education Department of Anhui Province (2022AH040160)
Anhui Provincial Special Fund for Clinical Medical Research Transformation (202304295107020040)
Shenzhen Science and Technology Innovation Program (JCYJ20240813151903006)
Article History
Received: 3 March 2026
Accepted: 12 July 2026
First Online: 17 July 2026
Declarations
Ethics approval and consent to participate: The animal study followed ARRIVE 2.0 guidelines, with a pre-established protocol, and was approved by the Animal Research Ethics Committee of Anhui Medical University (No. LLSC20240919). The institutional review board of Anhui Medical University and No.2 People’s Hospital of Fuyang City approved the study (No. 20210728 and No. 20250415113). All procedures involving human participants were performed in accordance with the Declaration of Helsinki and written informed consent was obtained from all patients.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.